insights_auto
Per què CMXHF ha baixat 3,91%?
Aprofundeix méschevron_right
CMXHF:OTCMKTS
CSL Ltd
121,10Â USD
arrow_downward
-3,91%(-4,93) 1d
9 d’oct., 16:00:00 GMT-4 · USD
search
Tots els sĂmbols
| SĂmbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadĂstiques principals per a CMXHF...
Obre
121,10Â USD
Alt
121,10Â USD
Baix
121,10Â USD
CapitalitzaciĂł borsĂ ria
88,22Â kM
Volum mitjĂ
151,00
Volum
479,00
Alt 52 setmanes
148,36Â USD
Baix 52 setmanes
63,84Â USD
VersiĂł beta
0,56
Accions en circulaciĂł
479,88Â M
Nombre d'empleats
29Â k
Obre
121,10Â USD
Alt
121,10Â USD
Baix
121,10Â USD
CapitalitzaciĂł borsĂ ria
88,22Â kM
Volum mitjĂ
151,00
Volum
479,00
Alt 52 setmanes
148,36Â USD
Baix 52 setmanes
63,84Â USD
VersiĂł beta
0,56
Accions en circulaciĂł
479,88Â M
Nombre d'empleats
29Â k
NotĂcies
De fonts web i partners de notĂcies
StreetInsider
·
fa 1 dia
Haemonetics stock surges 17% on CSL Plasma supply deal update
Pluang
·
fa 1 dia
Haemonetics shares rise 13% as CSL plans 2027 r...
Yahoo Finance
·
fa 1 dia
Haemonetics shares jump as CSL sets 2027 rollout of plasma devices
GuruFocus
·
fa 1 dia
Haemonetics (HAE) Shares Jump 14% Premarket on CSL Supply Agreem
Perfil
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
Sobre CSL Ltd
Conseller delegatPaul McKenzie
Empleats29Â k
FundaciĂł1916
Seu principalMelbourne, Victòria, Austrà lia
Sector-
Lloc webcsl.com